[HTML][HTML] Non-recovery from dialysis-requiring acute kidney injury and short-term mortality and cardiovascular risk: a cohort study
BMC nephrology, 2018•Springer
Background The high mortality and cardiovascular disease (CVD) burden in patients with
end-stage renal disease (ESRD) is well-documented. Recent literature suggests that acute
kidney injury is also associated with CVD. It is unknown whether patients with incident
ESRD due to dialysis-requiring acute kidney injury (AKI-D) are at higher short-term risk for
death and CVD events, compared with incident ESRD patients without preceding AKI-D.
Few studies have examined the impact of recovery from AKI-D on subsequent CVD risk …
end-stage renal disease (ESRD) is well-documented. Recent literature suggests that acute
kidney injury is also associated with CVD. It is unknown whether patients with incident
ESRD due to dialysis-requiring acute kidney injury (AKI-D) are at higher short-term risk for
death and CVD events, compared with incident ESRD patients without preceding AKI-D.
Few studies have examined the impact of recovery from AKI-D on subsequent CVD risk …
Background
The high mortality and cardiovascular disease (CVD) burden in patients with end-stage renal disease (ESRD) is well-documented. Recent literature suggests that acute kidney injury is also associated with CVD. It is unknown whether patients with incident ESRD due to dialysis-requiring acute kidney injury (AKI-D) are at higher short-term risk for death and CVD events, compared with incident ESRD patients without preceding AKI-D. Few studies have examined the impact of recovery from AKI-D on subsequent CVD risk.
Methods
In this retrospective cohort study, we evaluated adult members of Kaiser Permanente Northern California who initiated dialysis from January 2009 to September 2015. Preceding AKI-D and subsequent outcomes of death and CVD events (acute coronary syndrome, heart failure, ischemic stroke or transient ischemic attack) were identified from electronic health records. We performed multivariable Cox regression models adjusting for demographics, comorbidities, medication use, and laboratory results.
Results
Compared to incident ESRD patients who experienced AKI-D (n = 1865), patients with ESRD not due to AKI-D (n = 3772) had significantly lower adjusted rates of death (adjusted hazard ratio [aHR] 0.56, 95% CI: 0.47–0.67) and heart failure hospitalization (aHR 0.45, 0.30–0.70). Compared to AKI-D patients who did not recover and progressed to ESRD, AKI-D patients who recovered (n = 1347) had a 30% lower adjusted relative rate of death (aHR 0.70, 0.55–0.88).
Conclusions
Patients who transition to ESRD via AKI-D are a high-risk subgroup that may benefit from aggressive monitoring and medical management, particularly for heart failure. Recovery from AKI-D is independently associated with lower short-term mortality.
Springer